| 0 |
Serotonin-4 Receptor Agonist [EPC] |
19 |
0.0289 |
| 1 |
Dopamine-2 Receptor Antagonist [EPC] |
167 |
0.0214 |
| 2 |
Typical Antipsychotic [EPC] |
257 |
0.0103 |
| 3 |
Ergot Derivative [EPC] |
44 |
0.0089 |
| 4 |
Atypical Antipsychotic [EPC] |
3563 |
0.0079 |
| 5 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
3 |
0.0024 |
| 6 |
Tricyclic Antidepressant [EPC] |
1 |
0.0021 |
| 7 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
6 |
0.0016 |
| 8 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
32 |
0.0013 |
| 9 |
Phenothiazine [EPC] |
29 |
0.0010 |
| 10 |
Antifibrinolytic Agent [EPC] |
9 |
0.0009 |
| 11 |
Serotonin Reuptake Inhibitor [EPC] |
78 |
0.0009 |
| 12 |
Mood Stabilizer [EPC] |
180 |
0.0008 |
| 13 |
Neonatal Fc Receptor Blocker [EPC] |
3 |
0.0007 |
| 14 |
Progesterone [EPC] |
16 |
0.0007 |
| 15 |
Anti-epileptic Agent [EPC] |
146 |
0.0007 |
| 16 |
Androgen [EPC] |
17 |
0.0006 |
| 17 |
Benzodiazepine [EPC] |
412 |
0.0006 |
| 18 |
Central alpha-2 Adrenergic Agonist [EPC] |
32 |
0.0006 |
| 19 |
Glinide [EPC] |
5 |
0.0006 |
| 20 |
Orexin Receptor Antagonist [EPC] |
10 |
0.0005 |
| 21 |
Dopamine and Norepinephrine Reuptake Inhibitor [EPC] |
2 |
0.0005 |
| 22 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
4 |
0.0005 |
| 23 |
Central Nervous System Stimulant [EPC] |
45 |
0.0005 |
| 24 |
Intestinal Lipase Inhibitor [EPC] |
12 |
0.0005 |
| 25 |
Stimulant Laxative [EPC] |
7 |
0.0005 |
| 26 |
Antihypoglycemic Agent [EPC] |
2 |
0.0005 |
| 27 |
Gonadotropin [EPC] |
1 |
0.0005 |
| 28 |
Anticholinergic [EPC] |
7 |
0.0004 |
| 29 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
4 |
0.0004 |
| 30 |
Anthelmintic [EPC] |
1 |
0.0003 |
| 31 |
Histamine-1 Receptor Antagonist [EPC] |
28 |
0.0003 |
| 32 |
Monoamine Oxidase Inhibitor [EPC] |
1 |
0.0003 |
| 33 |
Calcitonin [EPC] |
1 |
0.0003 |
| 34 |
Somatostatin Analog [EPC] |
2 |
0.0003 |
| 35 |
Nitrofuran Antibacterial [EPC] |
5 |
0.0003 |
| 36 |
Carnitine Analog [EPC] |
1 |
0.0003 |
| 37 |
Photoenhancer [EPC] |
1 |
0.0003 |
| 38 |
Estrogen [EPC] |
46 |
0.0002 |
| 39 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
4 |
0.0002 |
| 40 |
Non-Standardized Plant Allergenic Extract [EPC] |
4 |
0.0002 |
| 41 |
Melatonin Receptor Agonist [EPC] |
3 |
0.0002 |
| 42 |
Paramagnetic Contrast Agent [EPC] |
1 |
0.0002 |
| 43 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
1 |
0.0002 |
| 44 |
Sympathomimetic-like Agent [EPC] |
6 |
0.0002 |
| 45 |
Recombinant Human Growth Hormone [EPC] |
4 |
0.0002 |
| 46 |
Ester Local Anesthetic [EPC] |
9 |
0.0002 |
| 47 |
Bismuth [EPC] |
1 |
0.0002 |
| 48 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
10 |
0.0002 |
| 49 |
Proton Pump Inhibitor [EPC] |
99 |
0.0002 |
| 50 |
Aldosterone Antagonist [EPC] |
25 |
0.0002 |
| 51 |
Human Immunoglobulin G [EPC] |
3 |
0.0001 |
| 52 |
Methylxanthine [EPC] |
8 |
0.0001 |
| 53 |
Progestin [EPC] |
39 |
0.0001 |
| 54 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
12 |
0.0001 |
| 55 |
Purine Antimetabolite [EPC] |
12 |
0.0001 |
| 56 |
5-alpha Reductase Inhibitor [EPC] |
12 |
0.0001 |
| 57 |
Non-Standardized Chemical Allergen [EPC] |
9 |
0.0001 |
| 58 |
Azole Antifungal [EPC] |
17 |
0.0001 |
| 59 |
Amide Local Anesthetic [EPC] |
9 |
0.0001 |
| 60 |
Cholinergic Nicotinic Agonist [EPC] |
6 |
0.0001 |
| 61 |
Pyridone [EPC] |
4 |
0.0001 |
| 62 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
1 |
0.0001 |
| 63 |
Sulfone [EPC] |
1 |
0.0001 |
| 64 |
Antiarrhythmic [EPC] |
9 |
0.0001 |
| 65 |
Aminosalicylate [EPC] |
9 |
0.0001 |
| 66 |
beta-Adrenergic Blocker [EPC] |
26 |
0.0001 |
| 67 |
Aluminum Complex [EPC] |
2 |
0.0001 |
| 68 |
Bile Acid Sequestrant [EPC] |
1 |
0.0001 |
| 69 |
HMG-CoA Reductase Inhibitor [EPC] |
29 |
0.0001 |
| 70 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
10 |
0.0001 |
| 71 |
Non-Standardized Food Allergenic Extract [EPC] |
6 |
0.0001 |
| 72 |
Asparagine-specific Enzyme [EPC] |
1 |
0.0001 |
| 73 |
Parenteral Iron Replacement [EPC] |
1 |
0.0001 |
| 74 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
1 |
0.0001 |
| 75 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
1 |
0.0001 |
| 76 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
2 |
0.0001 |
| 77 |
Acetylcholine Release Inhibitor [EPC] |
7 |
0.0001 |
| 78 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
90 |
0.0001 |
| 79 |
Protease Inhibitor [EPC] |
3 |
0.0001 |
| 80 |
Provitamin D2 Compound [EPC] |
2 |
0.0001 |
| 81 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
9 |
0.0001 |
| 82 |
Nicotinic Acid [EPC] |
4 |
0.0001 |
| 83 |
Vitamin D [EPC] |
19 |
0.0001 |
| 84 |
beta3-Adrenergic Agonist [EPC] |
3 |
0.0001 |
| 85 |
CTLA-4-directed Blocking Antibody [EPC] |
3 |
0.0001 |
| 86 |
Vitamin B12 [EPC] |
20 |
0.0001 |
| 87 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0001 |
| 88 |
Nitroimidazole Antimicrobial [EPC] |
4 |
0.0001 |
| 89 |
Prostaglandin E1 Analog [EPC] |
1 |
0.0001 |
| 90 |
Calcium [EPC] |
9 |
0.0001 |
| 91 |
Non-narcotic Antitussive [EPC] |
1 |
0.0001 |
| 92 |
Dihydropyridine Calcium Channel Blocker [EPC] |
19 |
0.0001 |
| 93 |
Vitamin C [EPC] |
23 |
0.0001 |
| 94 |
Corticosteroid [EPC] |
69 |
0.0001 |
| 95 |
Histamine-2 Receptor Antagonist [EPC] |
7 |
0.0001 |
| 96 |
Aromatase Inhibitor [EPC] |
6 |
0.0001 |
| 97 |
Cytochrome P450 3A Inhibitor [EPC] |
3 |
0.0000 |
| 98 |
Antimetabolite Immunosuppressant [EPC] |
1 |
0.0000 |
| 99 |
Programmed Death Ligand-1 Blocker [EPC] |
1 |
0.0000 |
| 100 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
4 |
0.0000 |
| 101 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
4 |
0.0000 |
| 102 |
Insulin [EPC] |
2 |
0.0000 |
| 103 |
Partial Opioid Agonist [EPC] |
4 |
0.0000 |
| 104 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 105 |
Folate Analog [EPC] |
2 |
0.0000 |
| 106 |
Loop Diuretic [EPC] |
18 |
0.0000 |
| 107 |
Vitamin A [EPC] |
2 |
0.0000 |
| 108 |
Fluoroquinolone Antibacterial [EPC] |
5 |
0.0000 |
| 109 |
Platelet Aggregation Inhibitor [EPC] |
22 |
0.0000 |
| 110 |
Interleukin-23 Antagonist [EPC] |
4 |
0.0000 |
| 111 |
Macrolide Antimicrobial [EPC] |
2 |
0.0000 |
| 112 |
Alkaloid [EPC] |
1 |
0.0000 |
| 113 |
Osmotic Laxative [EPC] |
11 |
0.0000 |
| 114 |
Microtubule Inhibitor [EPC] |
6 |
0.0000 |
| 115 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
4 |
0.0000 |
| 116 |
Leukotriene Receptor Antagonist [EPC] |
1 |
0.0000 |
| 117 |
Aromatic Amino Acid [EPC] |
2 |
0.0000 |
| 118 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
1 |
0.0000 |
| 119 |
CD20-directed Cytolytic Antibody [EPC] |
10 |
0.0000 |
| 120 |
Antidote [EPC] |
2 |
0.0000 |
| 121 |
Angiotensin 2 Receptor Blocker [EPC] |
10 |
0.0000 |
| 122 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1 |
0.0000 |
| 123 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
3 |
0.0000 |
| 124 |
Folate Analog Metabolic Inhibitor [EPC] |
13 |
0.0000 |
| 125 |
Opioid Agonist [EPC] |
8 |
0.0000 |
| 126 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 127 |
Expectorant [EPC] |
6 |
0.0000 |
| 128 |
Interleukin-12 Antagonist [EPC] |
3 |
0.0000 |
| 129 |
Alkylating Drug [EPC] |
7 |
0.0000 |
| 130 |
Tetracycline-class Drug [EPC] |
2 |
0.0000 |
| 131 |
Cardiac Glycoside [EPC] |
2 |
0.0000 |
| 132 |
Rifamycin Antibacterial [EPC] |
1 |
0.0000 |
| 133 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0000 |
| 134 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
5 |
0.0000 |
| 135 |
Topoisomerase Inhibitor [EPC] |
2 |
0.0000 |
| 136 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0000 |
| 137 |
Arteriolar Vasodilator [EPC] |
2 |
0.0000 |
| 138 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 139 |
Sulfonylurea [EPC] |
3 |
0.0000 |
| 140 |
Catecholamine [EPC] |
2 |
0.0000 |
| 141 |
Thiazide Diuretic [EPC] |
5 |
0.0000 |
| 142 |
Serotonin-3 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 143 |
Muscle Relaxant [EPC] |
1 |
0.0000 |
| 144 |
Prostaglandin Analog [EPC] |
2 |
0.0000 |
| 145 |
Interferon beta [EPC] |
4 |
0.0000 |
| 146 |
Insulin Analog [EPC] |
9 |
0.0000 |
| 147 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 148 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 149 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
2 |
0.0000 |
| 150 |
Platinum-based Drug [EPC] |
5 |
0.0000 |
| 151 |
Kinase Inhibitor [EPC] |
9 |
0.0000 |
| 152 |
Phosphodiesterase 5 Inhibitor [EPC] |
2 |
0.0000 |
| 153 |
alpha-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 154 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 155 |
Nucleoside Analog Antiviral [EPC] |
1 |
0.0000 |
| 156 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 157 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 158 |
Parathyroid Hormone Analog [EPC] |
1 |
0.0000 |
| 159 |
GLP-1 Receptor Agonist [EPC] |
3 |
0.0000 |
| 160 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 161 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
3 |
0.0000 |
| 162 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 163 |
Retinoid [EPC] |
1 |
0.0000 |
| 164 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |